1910 Genetics

Executive Assistant

Boston, Massachusetts, United States

$60,000 – $80,000Compensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
InternshipJob Type
UnknownVisa
Management Consulting, Administrative ManagementIndustries

Requirements

Candidates should possess a Bachelor's degree and demonstrate a minimum of 5 years of experience as an Executive Assistant, with a proven ability to manage complex calendars and coordinate executive travel arrangements. Strong organizational skills, discretion, and an understanding of business priorities are essential, along with experience in managing expense reports and supporting C-Suite executives. Familiarity with implementing administrative resources and documenting new policies and procedures is also required.

Responsibilities

The Executive Assistant will provide comprehensive support to executive members of the C-Suite by maintaining their calendars, coordinating meetings and events, making travel arrangements, and managing their timely expense reports. They will research and implement new administrative resources, tooling, policies, and procedures to ensure scalable support, monitor budget and financial reports for supported functions, and assist in honing internal company meeting cadence. Additionally, the role involves organizing and executing company-wide social team activities and retreats, managing relationships with vendors, overseeing the guest experience, and providing administration and project management support to various administrative functions including Business Operations, HR, and Finance.

Skills

Calendar Management
Travel Coordination
Expense Reports
Administrative Support
C-Suite Support
Policy Documentation
Vendor Management
Project Management
Budget Monitoring
Meeting Coordination

1910 Genetics

AI-driven drug discovery for challenging diseases

About 1910 Genetics

1910 Genetics focuses on improving drug discovery by combining artificial intelligence with biological research. Their technology helps identify and develop treatments for diseases that are hard to treat using traditional methods, specifically targeting "undruggable" parts of the human proteome. The company works with pharmaceutical firms, research institutions, and healthcare providers to create new small molecule drugs and protein therapeutics more efficiently. Unlike many competitors, 1910 Genetics offers a complete platform that covers the entire early drug discovery process, from target identification to treatment design. Their goal is to find effective therapies for challenging medical conditions, particularly through partnerships and grants, such as those from the National Institutes of Health.

Key Metrics

Boston, MassachusettsHeadquarters
2018Year Founded
$25.9MTotal Funding
GRANTCompany Stage
AI & Machine Learning, BiotechnologyIndustries
11-50Employees

Benefits

Extremely generous equity package
Competitive salary
Healthcare benefits
Generous vacation and parental leave
Super cool team building activities
Flexible work schedule

Risks

Increased competition from new AI entrants may erode market share.
Reliance on tech partnerships poses risks if strategic misalignments occur.
High R&D costs for 'undruggable' targets may impact financial sustainability.

Differentiation

1910 Genetics integrates AI, computation, and biological automation for drug discovery.
Their AI model, CANDID-CNS(TM), outperforms industry standards in blood-brain barrier prediction.
They focus on transforming 'undruggable' targets into treatable conditions.

Upsides

Accenture's investment enhances 1910 Genetics' AI platform and accelerates drug development.
Partnership with Microsoft leverages high-performance computing for drug discovery.
Strategic leadership appointments strengthen their position in AI-driven biotechnology.

Land your dream remote job 3x faster with AI